Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.123.266945 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Xiao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Melanins, Translational Research, Biomedical. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Abstract (Originalsprache)
Melanin is one of the representative biomarkers of malignant melanoma and a potential target for diagnosis and therapy. With advancements in chemistry and radiolabeling technologies, promising strides have been made to synthesize radiolabeled melanin-binding molecules for various applications. We present an overview of melanin-targeted radiolabeled molecules and compare their features reported in preclinical studies. Clinical practice and trials are also discussed to elaborate on the safety and validity of the probes, and expanded applications beyond melanoma are reviewed. Melanin-targeted imaging holds potential value in the diagnosis, staging, and prognostic assessment of melanoma and other applications. Melanin-targeted radionuclide therapy possesses immense potential but requires more clinical validation. Furthermore, an intriguing avenue for future research involves expanding the application scope of melanin-targeted probes and exploring their value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Molecular Imaging, Wuhan, China.
- Key Laboratory of Biological Targeted Therapy, Ministry of Education, Wuhan, China; and.
- Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China 13909245902@163.com lxl730724@hotmail.com.
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 13909245902@163.com lxl730724@hotmail.com.
Zitieren
APA
Zhang, X., Lin, Z., Feng, Y., Kang, F., Wang, J., & Lan, X. (2024). Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266945
Vancouver
Zhang X, Lin Z, Feng Y, Kang F, Wang J, Lan X. Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266945
BibTeX
@article{Zhang2024,
author = {Zhang, Xiao and Lin, Zhaoguo and Feng, Yuan and Kang, Fei and Wang, Jing and Lan, Xiaoli},
title = {Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.123.266945}
}
EUVIMED